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Abstract 
Artificial fluoridation, implemented worldwide to reduce periodontal diseases, was deemed 
one of the top public health achievements of the 20th century. In recent years, expert reviews by 
the US National Research Council (NRC) and the World Health Organization (WHO) have 
concluded children living in high-fluorosis areas may suffer from cognitive declines. However, 
exposure measures and statistical methods in past studies have been challenged, and, thus, the 
true relationship between fluoride exposure and cognition remains unclear. In addition, little is 
known about fluoride exposure during pregnancy.  
The objective of this dissertation is to improve understanding of fluoride exposures during 
pregnancy and to assess whether prenatal and concurrent fluoride exposure is associated with 
neurobehavioral effects in offspring. The research aims are conducted by using resources from 
the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) study, and a 
follow-up study called Cholesterol. Chapter 2 is the first population-based study to provide an 
exposure profile of fluoride during early, mid and late pregnancy, using two different 
biomarkers, and it is the first to examine whether some periods of pregnancy may be more 
vulnerable to exposure. Chapter 3 assesses the neurobehavioral effects of prenatal fluoride 
exposure on the Mental Development Index (MDI) of the children when they are one, two, and 
three years old.  Chapter 4 of this dissertation measures urinary fluoride in children at 6-15 years 
and examines its association to the total score from the Wechsler Abbreviated Scales of 
Intelligence Test (WASI.) This work increases our understanding of prenatal and concurrent 
fluoride exposure and their effects on cognition in children. During pregnancy, we found that 
	   xi 
fluoride levels do not change as pregnancy progresses once you adjust for other factors, and 
children of older mothers may be more susceptible to fluoride exposure. We additionally found 
that maternal fluoride exposure levels did not have any measurable effects on cognition in early 
childhood in this cohort. We found that concurrent fluoride exposure in males, but not females, 
aged 6-15 years, was significantly associated with WASI, and this highlights the need for future 
research considering gender differences in neurocognitive outcomes using longitudinal data. 
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CHAPTER I 
Introduction 
I. Background 
A. A brief history of water fluoridation 
Artificial fluoridation schemes have been used for nearly 65 years to reduce the 
prevalence of dental caries, but the relationship between fluoride and dental health stretches back 
further. At the turn of the 20th century, a handful of dentists in Colorado, Italy and England 
independently observed fewer dental caries in communities with naturally high fluoride levels in 
their water supply. The association between the compound and dental health was formally 
examined in 1945 when the National Institutes of Health (NIH) started an epidemiology study in 
Grand Rapids, Michigan in 1945. The city had just started fluoridating its drinking water supply, 
and the study found a 54 percent decrease in decayed, extracted or filled teeth in young children 
over the next 10 years.1,2,3 Following the publication of these promising findings, Sodium 
Fluoride (NaF) and fluorosilicates were increasingly and steadily added to public drinking water 
supplies in the United States and in other parts of the world.  
B. Adverse health related to fluoride ingestion 
Artificial fluoridation, however, has been controversial due, in part, to the adverse 
health outcomes associated with exposure. Moderate to severe intake of fluoride, for example, 
affects dental enamel. In some cases, the enamel is hypominerlized and in more severe cases, the 
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loss of enamel surface leads to brown stains on the surface of the teeth.4 Skeletal fluorosis, an 
abnormality in bone reformation, felt as joint pain and stiffness, is more serious and cases arise 
in communities where drinking water fluoride exceeds 4 mg/L. It can an also be an iatrogenic 
effect of fluoride therapy for osteoporosis.5 Fluoride exposure has also been implicated in lower 
serum testosterone in men exposed to more than 3 mg/L, in stomach and abdominal pain at 
levels less than 1 mg/L,6,7,8 in spina bifida occulta in high-fluorosis areas,9,10 and in lower IQ 
among children living in high fluorosis areas.11  
C. Fluoride exposure in the United States and in Mexico 
 
1. United States: In the United States(U.S.), fluoride is added to water as a  
preventive measure against dental caries. 12  Naturally fluoridated water, at the EPA’s 
recommendation, is maintained below 4 mg/L, the level above which the risk for skeletal 
fluorosis increases. Artificially fluoridated water is regulated by state and local governing bodies, 
but the U.S. Public Health service recommends 0.7 to 1.2 mg/L of fluoride for the prevention of 
dental caries. In 2012, 74.6% of people with access to public water systems or nearly 211 million 
people in the United States drank artificially fluoridated water.13 Another 13 million were 
reported to drink naturally fluoridated water in 1993, but no current data is available for this 
group.14 The World Health Organization reports either artificial or natural fluoridation in about 
30 countries worldwide.15 No data could be found on the number of pregnant women who are 
exposed to fluoride in the United States.   
2. Fluoride Exposure in Mexico: The participants for this study are from 
Mexico where fluoride levels in drinking fluids are comparable to fluoride levels in artificially 
fluoridated water in the U.S. Martinez-Mier et al. (2003)16 and Jimenez-Farfan et al. (2004)17 
measured 0.07-1.70 mg/L of fluoride in drinking water and other drinks from Mexico. Fluoride 
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measured in biomarkers like urine and plasma collected in the U.S. are also comparable to the 
values we found in our analyses of the Mexico City data. Plasma fluoride levels ranged from 
0.0035-0.0830 mg/L in our population with a mean of 0.0222 mg/L, which is comparable to the 
average of 0.019 mg/L found in an U.S. study. (Whitford, Thomas & Adair, 1999) Since the 
exposure levels in the U.S. and Mexico are comparable, an assessment of prenatal fluoride 
exposure and neurobehavior and its findings in the Mexican ELEMENT dataset would be 
applicable to the U.S. population as well. 
D. Concurrent fluoride and neurobehavior 
The epidemiology studies on fluoride and the brain have primarily come out of 
China. One study from the Guizhou region of China reported the mean IQ in medium fluorosis-
communities as 79.7 ± 12.7, and the mean IQ in severe fluorosis-areas as 80.3±12.9. These IQs 
were significantly lower than the mean IQ of 89.7±12.7 in slight fluorosis communities, and the 
mean of 89.9±10.4 in non-fluorosis communities (p<0.01.) The urinary fluoride levels in this 
region ranged from 1.02 to 2.69 mg/L which is comparable to the urinary fluoride concentrations 
measured in the ELEMENT preliminary analysis.18 While this and other studies19,20,21,22,23 point 
to a negative association between fluoride exposure and IQ, they are limited in design, size, and 
power. All of the reported studies use a cross-sectional design, measuring exposure and outcome 
once, and they do not adjust for critical confounders. Most of the studies also report ecological 
measures of exposure, an inaccurate indicator of exposure on an individual level and many of 
these do not have enough power to detect an association. This project, however, uses a large 
datatset with a prospective study design to assess the association between multiple personal 
measures of exposure and neurobehavior in hundreds of mother-infant pairs. This study also 
adjusts for critical confounders like parental education and child’s sex to study the effects of 
concurrent and prenatal exposure. Finally, none of the studies in the literature assess the effects 
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of exposure during fetal development, a particularly vulnerable period, and early childhood 
neurobehavior. 
E. Prenatal fluoride exposure 
1. Maternal-fetal transmission of fluoride 
Although the mechanisms of maternal fetal transmission of fluoride are poorly 
understood, there is considerable research showing maternally ingested fluoride can reach the 
fetus through the umbilical cord and placenta and ultimately increase fluoride levels in fetal 
tissue. Fluoride concentration of cord blood delivered to the fetus is moderately correlated with 
maternal blood fluoride, indicating that atleast some fluoride is leaving the maternal 
compartment and reaching the fetal compartment.24,25 Placental tissue has also provided evidence 
of fluoride transmission. The correlation between maternal blood fluoride and placental tissue 
fluoride is low, meaning the placenta is not trapping fluoride but allowing it to pass through to 
the fetus.26  Fluoride levels in fetal tissue further supports the hypothesis that fluoride traverses 
the umbilical cord and the placenta. In studies where women and animals take-in fluoride during 
pregnancy, concentrations in fetal tissue increase as intake increases. Higher concentrations of 
fluoride were found in fetal brain tissue27,28 and dental enamel29 from animals fed higher 
amounts of fluoride than control animals.  Even though maternal intake is the safest and easiest 
proxy for fetal exposure to fluoride, there exist very few timely and reliable studies on fluoride 
exposure in pregnant women. 
2. Fluoride in pregnant women 
There are a handful of studies that report on exposure in pregnant women, but most of 
them date back several decades, and they lack rigorous study methods, longitudinal measures 
and multiple biomarkers.30,24,31,32,33,34 The studies reviewed were published primarily in the 
1960s and 70s and the largest of them recruited 32 people so, they do not provide a current or 
5 
reliable representation of fluoride levels in pregnant women. The cross-sectional measures taken 
from these women are also not representative of fetal exposure for all stages of the pregnancy. 
Most of the reported fluoride measures are from the third trimester, but research on other 
contaminants like lead35, 36and mercury37,38 demonstrate that contaminant levels can change as 
pregnancy progresses with different implications for health. The only known study to take 
multiple fluoride measures was published in 1959 in Jerusalem so it is not timely or relevant to 
the U.S. population.39  The fluoride studies listed above also only report on a single biomarker of 
exposure, blood fluoride, but multiple biomarkers can provide more data on acute and chronic 
exposure. Lastly, these studies provide no data on socioeconomic or demographic factors that 
may affect exposure in women. The second chapter of this dissertation, however, is the first 
exposure study to report fluoride status in hundreds of pregnant women by using two 
biomarkers, urine and plasma, that were collected multiple times during pregnancy. It also 
reports on the maternal and demographic factors that can affect pregnancy fluoride status. 
3. Prenatal fluoride exposure and the brain
Following the assessment of prenatal exposure, the third chapter of this dissertation 
presents a novel study on the neurobehavioral effects of exposure in the womb. There are 
currently no reports on this association, but previous studies report structural damage to fetal 
brain tissue after fluoride exposure and this begs the question, what if any, lingering effects 
remain from this exposure. In two human studies from China, brains were collected from five to 
eight month old fetuses that were aborted in high fluorosis and low fluorosis areas. The brains 
from the high fluorosis areas contained higher fluoride (0.28± 0.14 µg/g) than brains from low 
fluorosis areas (0.19± µg/g) (p<0.05) Brain tissue from the fluorosis endemic area also contained 
fewer neurons in the brain cortex with smaller volumes. In the cerebellum, the Purkinje fibers of 
the control brains were organized, but they were disorganized in the brains from the endemic 
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region.40 In another similar study in the same region of China, fewer neurotransmitters like 
norepinephrine, 5-hydroxytryptamine, and α1-receptor were measured in brains from endemic 
areas compared to controls.41 In one rat study, pregnant dams subcutaneously injected with 
sodium fluoride (NaF) birthed male pups that were more hyperactive than the control pups.42 In 
two other rat studies, fluoride was measured in brain tissue and histopathological changes were 
noted in the brains of rats exposed to fluoride during gestation and lactation. Pups exposed to 
100 ppm and 200 ppm of fluoride had significantly more fluoride in their cerebral cortex, 
medulla and cerebellum than controls rats43 In another paper, Shivarajashankara et al. (2002)44 
published photomicrographs of shrunken neurons and decreased cell numbers in the 
hippocampus, amygdala, motor cortex and cerebellum of pups exposed to 100 ppm fluoride 
during gestation and lactation. The implications of this damage on postnatal neurobehavior 
remain unstudied, however, so, the third chapter of this dissertation reports on the effects of this 
exposure on childhood cognition. It is the first study to do so, and it measures maternal exposure 
and reports its association to child cognition during the first three years of life.  
II. Methods
A. Study Population 
The mother-infants pairs for this study were recruited from the Early Life Exposures in 
Mexico to Environmental Toxicants (ELEMENT) study, a long-running, award-winning, 
NIEHS-funded series of birth cohorts that were established to study the developmental effects of 
toxicants. The study is based out of Mexico City, Mexico, and participants were recruited during 
their prenatal visits to one of three clinics of the Mexican Institute of Social Security. Women 
who had a positive pregnancy test, who lived in Mexico City and who were willing to participate 
in the study were recruited after they were informed of the study procedures and after they 
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provided written consent. Women in the following categories were excluded from the study: 
those with psychiatric disorders, those who consumed alcohol daily or were addicted to illegal 
drugs, those who continuously used prescription drugs and those who were at risk for high-risk 
pregnancies, pre-eclampsia, renal or circulatory diseases including hypertension, those with 
gestational diabetes, those who suffered from seizures that required medical attention and those 
who were more than 14 weeks pregnant.35
1. Participants for prenatal studies
Participants for the prenatal exposure portion of this project were recruited between 1997 
and 2005. Each woman contributed between one and three urine samples and between one and 
three plasma samples during the course of her pregnancy. These samples were frozen at the field 
site and then transferred to Harvard University and the University of Michigan. After the 
delivery, the infants were administered neurobehavioral tests at ages one, two and three to 
continually assess their development.  
2. Participants for concurrent exposure study
Participants for the concurrent fluoride and neurobehavior portion of this project were a 
subset of children recruited from ELEMENT for a follow-up study on lead and neurobehavior. 
1272 of the mother-infant pairs eligible to participate in the follow-up were approached between 
2008 and 2010, urine samples were available for 653 pairs. The mothers consented to the study, 
children gave assent, and IRB approval was obtained at the University of Michigan and at the 
National Institute of Public Health of Mexico.  
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B. Biomarkers 
1. Urinary fluoride
Urinary fluoride, an indicator of acute exposure to fluoride, was measured in urine 
samples collected from pregnant subjects. The Agency for Toxic Substances and Disease 
Registry (ATSDR) manual on fluoride reports that urine is the most commonly measured marker 
in fluoride studies.45  A number of studies have found a high correlation between fluoride 
concentrations in ingested water and urinary fluoride, with one study finding a 98% correlation 
between daily fluoride intake in water and fluoride excreted in urine.46 There are no studies 
measuring the association between chronic fluoride exposure and urinary fluoride, but urine 
fluoride levels are closely associated with acute fluoride intake.45 (Figure 1)47 
2. Plasma fluoride
Plasma fluoride, a measure of chronic exposure to fluoride, on the other hand, increases 
drastically within the first hour of ingestion of fluoride, and starts decreasing within 20 minutes 
of fluoride ingestion because some fluoride is excreted in the urine and some is incorporated into 
the bone. (Figure 1)47 Overtime, some of the bone fluoride is also released from the bone, and 
back into the plasma, making plasma a good measure of chronic exposure to fluoride.47  
C. Neurobehavioral tests 
1. Wechsler Abbreviated Scales of Intelligence (WASI)
A Spanish-version of the Wechsler Abbreviate Scale of Intelligence (WASI) was 
administered to the children during their baseline visit. Trained members of the Mexico team, to 
whom the fluoride status of the children was unknown, administered the test. Total WASI score, 
the measure assessed in this study, was calculated by combining sub-scores that measured verbal 
and executive function.  
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2. Bayley Infant Scales of Development-II (BSID-II) and the Mental
Development Index (MDI) 
The existing studies on fluoride and neurobehavior primarily use IQ as the outcome of 
interest11,48,49 but, as the NRC highlights, there are no studies reporting on the effect of fluoride 
on other critical neurobehavioral outcomes like memory or problem solving.14 In ELEMENT, 
one, two and three-year olds were tested on multiple outcomes when we administered a Spanish-
version of the BSID-II test to measure mental, motor and behavioral skills. The BSID-II is a 
validated and widely used test for children between the ages of six and 42 months.  
In this fluoride study, the Mental Development Index (MDI) subscale, which measures 
problem solving, language and social skills, was used.50 Research on other environmental agents 
like phthalates, lead and manganese has found MDI to be sensitive enough to detect the effect of 
prenatal and postnatal toxicant-exposure on mental development in children in our age range of 
interest. In the phthalate study, maternal urinary levels of the substance were inversely associated 
with MDI at age three.51 The lead and manganese studies detected an association in the 
ELEMENT dataset; MDI decreased as lead levels increased in two year olds,52 and MDI was 
adversely affected at lower and higher manganese concentrations in one year old children.53 
There are no published studies of prenatal or postnatal exposure to fluoride and its effects on 
MDI, but in one animal study, mice drinking fluoridated water lagged in learning and memory, 
components of the MDI scale.54 This project uses this measure to assess the effects of fluoride on 
mental function in young children.  
III. Thesis overview
The objective of this dissertation is to improve understanding of fluoride exposures 
during pregnancy and to assess whether prenatal and concurrent fluoride exposure is associated 
with neurobehavioral effects in offspring. The research aims are conducted by using resources 
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from the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) study, and a 
follow-up study called Cholesterol. Chapter 2 is the first population-based study to provide an 
exposure profile of fluoride during early, mid and late pregnancy, using two different 
biomarkers, and it is the first to examine whether some periods of pregnancy may be more 
vulnerable to exposure. Chapter 3 assesses the neurobehavioral effects of prenatal fluoride 
exposure on the Mental Development Index (MDI) of the children when they are one, two, and 
three years old.  Chapter 4 of this dissertation measures urinary fluoride in children at 6-15 years 
and examines its association to the total score from the Wechsler Abbreviated Scales of 
Intelligence Test (WASI.) This work increases our understanding of prenatal and concurrent 
fluoride exposure and their effects on cognition in children. During pregnancy, we found that 
fluoride levels do not change as pregnancy progresses once you adjust for other factors, and 
children of older mothers may be more susceptible to fluoride exposure. We additionally found 
that maternal fluoride exposure levels did not have any measurable effects on cognition in early 
childhood in this cohort. We found that concurrent fluoride exposure in males, but not females, 
aged 6-15 years, was significantly associated with WASI, and this highlights the need for future 
research considering gender differences in neurocognitive outcomes using longitudinal data.	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Figures and Tables 
Figure I.1: Fluoride metabolism 
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CHAPTER II  
Urinary and Plasma Fluoride Levels During Pregnancy and Determinants of Exposure 
Among Pregnant Women from Mexico City, Mexico 
I. Abstract 
Background: Maternal fluoride exposure can be used as a proxy for fetal exposure but there is 
limited knowledge of fluoride exposure during pregnancy.  
Objective: We utilize The Early Life Exposure in Mexico to Environmental Toxicants 
(ELEMENT) multi-year birth cohort to measure urine and plasma fluoride in pregnant women 
(N=810). We assess biomarker stability across pregnancy and the effects of maternal variables 
on exposure.  
Methods: Samples from trimester 1 (471 urine, 231 plasma), trimester 2 (441 urine, 268 plasma) 
and trimester 3 (261 urine, 158 urine) were analyzed using an ion-selective electrode. Intra-class 
correlation coefficient (ICC) was calculated for urine and plasma samples across trimesters. 
Linear mixed models, adjusted for maternal education, age, marital status and smoking during 
pregnancy, were run to assess their effect on maternal urine and plasma levels during pregnancy. 
Plasma fluoride was included as a covariate in the urine model and vice-versa. 
Results: Urinary fluoride averaged 0.869mg/L and ranged from 0.099 to 4.042 mg/L. Plasma 
fluoride averaged 0.0222mg/L and ranged from 0.0035 to 0.0830mg/L. No significant 
 18 
correlation was found between average urinary fluoride and average plasma fluoride (R= -0.046, 
p=0.48) Urinary fluoride was not stable across pregnancy (ICC=0.167) and the same was found 
for plasma fluoride across the trimesters of pregnancy (ICC=0.344). Women who smoke had 
higher urinary fluoride than non-smokers, older women had higher plasma fluoride, and women 
carrying female children had a lower plasma fluoride. 
Conclusion: This is the first large-scale epidemiology study to measure urine and plasma 
fluoride in hundreds of pregnant women. These measures could be proxies for fetal exposure, 
and they have implications for future health outcomes research. The low ICC values suggest that 
fluoride values are not stable across trimesters. This is significant for future research which will 
examine windows susceptible to fluoride exposure during pregnancy. We also found that 
smokers have higher urinary fluoride, and older mothers have higher plasma fluoride, potentially 
making them more vulnerable to exposure.  
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II. Introduction
Artificial fluoridation has been used for nearly 60 years to reduce the prevalence of 
periodontal disease. A number of publications recommend prenatal supplements as a measure to 
prevent childhood caries,1,2 and some studies recommend fluoride supplements during 
pregnancy.3 An estimated 210 million people in the United States4 and millions more across 30+ 
countries drink water that is artificially fluoridated.5 Despite clear benefits, there remains 
continued debate over fluoride supplementation because fluoride intake has been shown to cause 
adverse effects on teeth,6 bones,7,8 and cognition.9 Given the controversy, a committee of experts 
was convened by the US National Research Council (NRC) to address the potential impacts of 
population levels of fluoride exposure on a number of adverse health outcomes, such as dental 
and skeletal fluorosis, carcinogenicity, and reproductive, developmental and endocrine effects.10 
The postnatal effects of fluoride have been studied in children and adults, but few studies have 
examined health outcomes associated with prenatal exposures.  This despite some 
epidemiological and animal evidence suggesting that fluoride is a developmental neurotoxicant11 
Developmental exposures to fluoride are possible as studies have shown that fluoride ingested by 
the mother reaches the fetus through the umbilical cord and placenta. Maternal blood fluoride, 
for example, is moderately correlated with cord blood, indicating that at least some fluoride 
leaves the maternal compartment and reaches the fetal compartment.12,13 Placental tissue also 
provides evidence of this transmission through a lack of significant correlation between maternal 
blood fluoride and placental tissue. Once in the fetus, fluoride levels in the brain14,15 and teeth16 
increase in accordance with maternal exposures. The aforementioned studies suggest that the 
fetus is exposed to fluoride, and that maternal fluoride levels can be used as a proxy for fetal 
exposure.12 
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There exist a handful of studies that have reported upon fluoride exposure in pregnant 
women, however these studies generally date back several decades, provide limited data on 
socioeconomic or demographic variables that could modify exposure or risk, and lack rigorous 
methods like robust sample sizes, multiple biomarkers, repeated measures, or demographic 
information; 5,13, 17,18,19,20,21 For instance, the largest of the aforementioned papers recruited less 
than 100 women, and most of the fluoride measures were obtained from single biomarker taken 
from the third trimester and at delivery. However, research on other contaminants like 
mercury22,23 demonstrate that exposure levels can change as pregnancy progresses (i.e., that 
developmental windows of susceptibility exist), and that different biomarkers can give distinct 
information on the source, duration and severity of exposure.24 
The general objective of the current study was to increase understanding of 
developmental exposure to fluoride by establishing a profile of prenatal exposure. To achieve 
this we characterized fluoride levels in archived urine and plasma samples (which indicate acute 
and chronic exposure, respectively) from pregnant mothers from three trimesters.  The mothers 
were enrolled in the Early Life Exposure to Environmental Toxicants (ELEMENT) study which 
is a sequentially enrolled epidemiologic birth cohort series running since 1994.  
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III. Methods
Study Population 
Study participants were recruited between 1997 and 2005 from three clinics of the Mexican 
Institute of Social Security (IMSS) in Mexico City, Mexico as part of the ELEMENT study. 
Pertinent details of ELEMENT, such as inclusion and exclusion criteria, collection methods, and 
demographics can be found elsewhere.25  Briefly, each woman in the study contributed between 
one and three urine and plasma samples during pregnancy, and these were stored frozen. For this 
particular study, a subset of available samples from trimester one (471 urine, 239 plasma), two 
(441 urine, 278 plasma), and three (261 urine, 163 plasma) were studied. Corresponding 
gestational month values and a range of demographic variables were available for these 
participants. The institutional review boards of the National Institute of Public Health of Mexico, 
University of Michigan, the University of Toronto, the Harvard School of Public Health and 
participating clinics approved the study procedures.  
Fluoride in Urine Samples 
The free ionic form of fluoride was measured in urine samples using an ion-selective 
electrode-based assay26 at the University of Michigan School of Public Health. Briefly, urine was 
diluted with equal parts Milli-Q water in a petri dish, and allowed to react for 20-24 hours with 3 
M sulfuric acid saturated with hexamethyldisiloxane (HMDS). The diffused fluoride was 
collected in 0.05 M of sodium hydroxide that was spotted on the interior of the petri dish cover. 
Following neutralization with 0.25 M of acetic acid, the concentration of fluoride in this solution 
was determined using an ion-selective electrode (Orion Fluoride Combination Electrode). 
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Urinary reference standards obtained from the Institut National de Santé Publique du 
Québec (INSPQ) were used to gauge analytical accuracy and precision. The average recovery 
rate for the standards was 100%.  In addition, each batch run contained procedural blanks and 
replicate runs. The mean percent relative percent standard deviation for all samples was below 
20%. The analytical detection limit (mean: 0.00656mg/L; range: 2.30*10-6 – 0.10mg/L) was 
calculated as the mean blank value plus two times the standard deviation. A subset of urine 
samples was also measured at the Indiana University Oral Health Research Institute (OHRI). The 
correlation coefficient between the two laboratories was 0.873.  
Fluoride in Plasma Samples 
Plasma samples were measured for fluoride at the Indiana University Oral Health Research 
Institute (OHRI) using the hexamethyldisiloxane (HMDS) microdiffusion method of Taves 
(1968) as modified by Martinez-Mier et al. (2011). Briefly, plasma sample diluted 2:1 with 
diH2O was pipetted into a plastic Petri dish, with a trap solution of 0.075 N sodium hydroxide 
(NaOH) placed on each dish lid.  Each dish was immediately sealed.  Next, HMDS-saturated 3 N 
SO4 was introduced into each sample via a small hole burned into each lid.  The hole was sealed 
immediately with petroleum jelly. During overnight diffusion, fluoride was released and trapped 
in the NaOH. The trap was recovered and buffered to pH 5.2 with acetic acid (CH3COOH). The 
recovered solution was adjusted to a final volume of 20 ml with diH2O. A standard fluoride 
curve was prepared from similarly diffused fluoride standard solutions and used to determine 
fluoride content of each plasma sample.  Millivolt readings were measured using a fluoride 
micro-electrode (Microelectrodes, Inc MI-SO) and pH/ISE meter (Orion Dual Star or 
equivalent). Duplicate analyses were done in sets of approximately 30-40 samples.   
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Statistical Analysis 
Histograms of urinary and plasma fluoride were generated to view the distribution of exposure 
levels, and summary measures like the mean and median were calculated. Intraclass correlation 
coefficients (ICC) were calculated to assess the stability of the two biomarkers throughout 
pregnancy, and Spearmann correlation coefficients were generated to test the correlation between 
the biomarkers of exposure and other demographic variables. The differences in exposure levels 
across maternal age and maternal smoking status were compared using t-tests and boxplots. 
Linear mixed models, adjusted for maternal education, age, marital status, and smoking during 
pregnancy, were run to assess their effect on maternal urine and plasma levels during pregnancy. 
Data were analyzed using R 0.98.507 (RStudio, Inc.) and SAS 9.2 (SAS Institute Inc. Cary, NC).  
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IV. Results
Fluoride measurements were drawn from ELEMENT mothers (N=810) for whom we had 
at least one prenatal biomarker.  Characteristics of these mothers (age: 26.6 ± 5.4 years; maternal 
education: 10.7 ± 3 years; 89.36% married or cohabitating) were not statistically different from 
mothers excluded due to not having a prenatal biomarker measurement. The number of mothers 
for whom we have prenatal fluoride biomarker measurements from early, mid, or late trimester 
(Nurine=471, 441, 261; Nplasma= 231, 268, 158, respectively), and those for whom we have one, 
two, or all three of the measurements (Nurine=341, 230, 124; Nplasma = 120, 144, 83 respectively) 
varies.   
Every urine and plasma sample investigated had detectable levels of fluoride. Urinary 
fluoride levels in this population of pregnant women ranged from 0.099 to 4.042 mg/L with a 
mean of 0.869.  Plasma fluoride levels were significantly (p<0.001, Student t-test t= 23.47) lower 
than urinary fluoride levels with a mean of 0.0222 mg/L, and they ranged from 0.0035 to 0.0830 
mg/L (Table 1).  
No significant spearman correlations were found between urinary and plasma fluoride 
during trimester 1(ρ=0.066, p=0.612), 2 (ρ= -0.011, p=0.895) or 3 (ρ=-0.078, p=0.616), but 
significant correlations were found between urine across trimesters and plasma across trimesters. 
Correlation values for urine showed that fluoride levels in prior trimesters predicted significantly 
higher urinary fluoride in subsequent trimesters (ρ1-2 = 0.200, p=<0.01; ρ1-3 = 0.201; p=<0.01; 
ρ2-3 = 0.284, p<0.01.) A similar association was found between trimester 1 and 2 plasma (ρ = 
0.453; p=<0.01) and trimester 2 and 3 plasma (ρ = 0.382; p=<0.01.) Across the three trimesters, 
maternal urinary fluoride values were not significantly different and remained fairly stable as 
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pregnancy progressed. As a summary measure of correlation across trimesters, the ICC for urine 
was 0.166 and for plasma was 0.347.
Two linear mixed effects models, with average urine or average plasma as the outcome 
for each, were run after adjusting for education, age, marital status and smoking during 
pregnancy. Lower urinary fluoride was detected in those who do not smoke during pregnancy 
(β= -0.517, 95% CI: -0.879, -0.154), higher plasma fluoride in older mothers (β= 0.0005, 95% 
CI: 8.7*10-5, 0.0008) and lower plasma fluoride in mother’s carrying female children (β= -
0.0030, 95% CI: 7.1*10-3, 0.0011). No other significant associations were found. (Table 3) In 
another analysis, plasma fluoride was included as a dependent variable in the urinary fluoride 
model, and urinary fluoride as a dependent variable in the plasma model, but no significant 
associations were detected between the two biomarkers.  
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V. Discussion 
Here we report upon urinary and plasma biomarkers of fluoride exposure from pregnant 
women of Mexico City. We believe that this is the first large epidemiology study to report 
fluoride exposure during multiple timepoints of pregnancy using two different biomarkers. 
Where other studies have only provided exposure data for the last trimester and delivery, our 
study also examined exposure trends from the first month through delivery and found that 
fluoride levels do not change as pregnancy progresses once you adjust for other factors. Finally, 
we showed that women who smoke and older women maybe more susceptible to fluoride 
exposure.   
This is the first study to report urinary and plasma fluoride levels in hundreds of pregnant 
women from a population drinking fluoridated water at levels recommended by the U.S. Public 
Health Service. Urinary fluoride ranged from 0.902-3.439 mg/L and plasma fluoride range from 
0.004-0.077 mg/L. The levels of fluoride in maternal urine and plasma reported within this study 
are similar in range to other reports. In a study where women drank 1 mg/L of fluoridated water, 
urinary fluoride ranged from 0.22 to 0.53 mg/L.20 In a controlled clinical study, pregnant women 
taking fluoride supplements had a mean urinary fluoride of 1.03±0.14mg/day in early 
pregnancy.27  The wider range of urinary fluoride found in this study could be explained by 
higher levels of exposure in our population. Similarly, the plasma levels we report in this study 
are comparable to the levels reported in other studies on pregnant women. The most recent study, 
from Poland, measured 0.0329-0.0373 mg/L of plasma fluoride in 35 women during the third 
trimester of pregnancy,3 while other studies measured a range of 0.011-0.050 mg/L of plasma 
fluoride in five women,28 a mean of 0.033±0.003 mg/L in 50 women29 and 0.97±0.22 (first 
trimester), 0.90±0.25 (second trimester), 0.86±0.18micromol/liters in 68 women.30  
 27 
An issue of increasing importance is determining whether there are time-related exposure 
windows of susceptibility to toxicant exposures especially during the prenatal period. Many lines 
of evidence now indicate such, including previous work by us concerning lead exposure in the 
ELEMENT cohort.31,32 Here we were able to study whether fluoride levels vary in urine and 
plasma as pregnancy progressed, however we only saw changes on the individual level while the 
population averages remained stable throughout pregnancy. This was somewhat surprising to us 
as a number of physiological and metabolic changes occur during pregnancy that could affect 
fluoride toxicokinetics. Previous studies reported significantly different levels of exposure 
between different periods of gestation. One study from Jerusalem, for example, reports an U-
shaped distribution with the highest concentration of urinary fluoride measured in the fourth and 
ninth months of pregnancy.20 The other study on plasma pregnancy did not report any significant 
differences in plasma fluoride between the 28th and the 33rd week of pregnancy.3  
Here we were also able to study urinary and plasma fluoride values in relation to key 
demographic variables.  The strongest changes in plasma fluoride were in relation to maternal 
age, with older mothers reporting significantly higher levels of plasma fluoride.  This may be 
explained by the exchange of fluoride between plasma and bone during the aging process. 
Ingested fluoride is absorbed through the gut, taken into the plasma, and then deposited into the 
bone. As the organism ages, the hydroxyapatite mineral in bone becomes saturated with fluoride, 
and further deposition of the ion from plasma is prevented.7,33 In animal studies, older dogs34 and 
rats35 had more fluoride in their plasma than their younger counterparts, further supporting the 
theory that fluoride remains in the plasma or is excreted through the urine than deposited in the 
bone. There are, however, no such studies on plasma clearance in pregnant animals or humans 
so, this warrants more study.  
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Finally, we have limited evidence that suggests that urinary fluoride may be higher in 
women who smoke during pregnancy. This increase may be explained by the mobilization of 
fluoride during bone resorption. Fetal demands for calcium, particularly during the third 
trimester, increase the rate of bone breakdown to release the mineral into the bloodstream.36,37,38 
To our knowledge, the effect of smoking on this process during pregnancy has not been studied; 
however, the catalytic effect of smoking on bone resorption in non-pregnant adults has been well 
documented.39 Higher concentrations of the deoxypyridinoline, C-telopeptide,40 and N-
telopeptide, 41 markers of bone breakdown, were measured in smokers. When bone resorption 
exceeds bone formation, as is the case in smokers, the amount of fluoride released from the bone 
increases without an increase of incorporation of fluoride into the bone.7 We hypothesize that 
urinary fluoride levels, in turn, increase as the body attempts to clear the release of excess 
fluoride from the bones.  
Despite a number of strengths (e.g., large sample size, multiple biomarkers, demographic 
factors), there are potential limitations of our study that need mention. The spot urine samples we 
measured cannot account for diurnal variations in urinary fluoride. Previous studies report 
fluctuations in concentration by time-of-day42 which means that the fluoride levels in our 
samples could be influenced by the time-of-collection or by diet. Future studies should either 
provide 24-hour measures or measure samples that have been collected at a standard time. This 
study was also not initially designed to address fluoride exposure, but we have strong biomarkers 
and the fluoride levels we measured were similar to previous reports.  
Regardless, our work provides the most reliable characterization to date of urinary and 
plasma fluoride throughout the duration of pregnancy. Our values were similar to the ones 
reported in previous studies, but contrary to other reports, our analysis did not show a significant 
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trend in urine or plasma fluoride once we adjusted for maternal and demographic factors. The 
two biomarkers were largely stable from the first to the last month of pregnancy. Interestingly, 
mothers who smoke seem to have the highest amount of urinary fluoride, and older mothers have 
the highest plasma fluoride, indicating that fetal exposure could be higher among smokers and 
older women. These results will be used in future studies related to health outcomes research 
such as prenatal fluoride exposure and neurobehavior.  
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Tables	  and	  Figures	  
Table II.1: Exposures in Mexico to Environmental Toxicants (ELEMENT) cohort recruited in Mexico City, 
Mexico between 1997 and 2005. 
N Mean SD Min 10% 25% 50% 75% 90% Max 
Urinary 
Fluoride 
Early 
pregnancy 471 0.838 0.500 0.073 0.302 0.446 0.761 1.099 1.450 4.042 
Mid 
pregnancy 441 0.865 0.540 0.110 0.308 0.463 0.778 1.096 1.566 3.439 
Late 
pregnancy 261 0.883 0.573 0.057 0.306 0.460 0.787 1.161 1.547 4.042 
Average 
Urinary 
Fluoride 
695 0.869 0.483 0.099 0.351 0.527 0.814 1.089 1.450 4.042 
Plasma 
Fluoride 
Early 
pregnancy 231 0.0228 0.0221 0.0021 0.0045 0.0070 0.0144 0.0312 0.0559 0.1052 
Mid 
pregnancy 268 0.0196 0.0169 0.0022 0.0052 0.0077 0.0139 0.0241 0.0426 0.0830 
Late 
pregnancy 158 0.0180 0.0170 0.0028 0.0045 0.0066 0.0115 0.0234 0.0426 0.0819 
Average 
Plasma 
Fluoride 
347 0.0222 0.0167 0.0035 0.0066 0.0090 0.0171 0.0296 0.0464 0.0830 
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Table II.2: Intraclass correlation of urinary fluoride and plasma fluoride over three trimesters of pregnancy and 
Spearman correlation coefficients of trimester-specific urine and plasma fluoride among pregnant women from 
Mexico City, Mexico.  
Intraclass Urine  Plasma  
Correlation 
Coefficient 
Trimester 1 Trimester 2 Trimester 3 Trimester 1 Trimester 2 Trimester 3 
U
ri
ne
 
Trimester 1 
0.167 
1.00 
471 
0.200** 
0.0028 
246 
0.201** 
0.0067 
181 
0.066 
0.612 
61 
-0.225* 
0.0713 
65 
0.074 
0.619 
47 
Trimester 2 1.00 
441 
0.284** 
0.0001 
175 
-0.093 
0.329 
113 
-0.011 
0.895 
154 
-0.0600 
0.602 
79 
Trimester 3 1.00 
261 
-0.031 
0.806 
66 
0.160 
0.181 
72 
-0.0778 
0.616 
44 
Pl
as
m
a 
Trimester 1 
0.344 
1.00 
231 
0.453** 
<0.001 
169 
0.158 
0.150 
85 
Trimester 2 1.00 
268 
0.382** 
<0.0001 
139 
Trimester 3 1.00 
158 
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Table II.3: Generalized Additive Mixed Effects models with maternal urinary fluoride and 
plasma fluoride as outcome measures in hundreds of pregnant women from Mexico City, 
Mexico. 
Urinary Fluoride Plasma Fluoride 
Parameter 
Estimate 
95% 
Confidence 
Interval 
Parameter 
Estimate 
95% 
Confidence 
Interval 
Intercept 1.335 0.898, 1.771 0.0156 -3.50*10-3, 
0.0347 
Maternal 
Education 
-0.011 -0.026, 0.003 -0.0007 1.4251*10-3, -
0.000017 
Maternal Age 
(Continuous) 
0.006 -0.002, 0.0137 0.0005 8.667*10-5, 
0.0008 
Marital Status 
(ref.=Married) 
-0.093 -0.233, 0.048 -0.0030 -1.00*10-2, 
0.0040 
Maternal 
Smoking 
During 
pregnancy 
(ref=yes) 
-0.517 -0.879, -0.154 0.0039 -1.046*10-2, 
0.0184 
Child’s Sex 
(ref=male) 
-0.009 -0.095, 0.077 -0.0030 7.093*10-3, 
0.0011 
Gestational 
Months 
0.009 -0.008, 0.026 -0.0003 -1.051*10-3, 
0.00037 
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CHAPTER III  
Prenatal fluoride exposure and neurobehavior: a prospective study 
I. Abstract 
Background: Recent studies report an inverse association between fluoride exposure and IQ in 
children, but few utilized personal measures of exposure or assessed associations with prenatal 
exposure using a prospective study design.  
Methods: This study utilizes the Early Life Exposures in Mexico to Environmental Toxicants 
(ELEMENT) birth cohort and associated archived pregnancy samples to study prenatal fluoride 
exposure and its association with subsequent child neurobehavioral outcomes at ages 1, 2 and 3. 
Generalized Additive Mixed Models were used to model the association between urinary 
fluoride (N=431) and Mental Development Index (MDI), a subscale of the Bayley Scales of 
Infant Development-II (BSID-II) test. A similar model was estimated for plasma fluoride 
(N=194). Both models controlled for maternal age, education, marital status, pregnancy smoking 
status, child’s sex, and child’s age.  
Results: The median for urinary fluoride was 0.831mg/L (0.110, 3.439), and the median for 
plasma fluoride was 00.01600mg/L (0.0035,0.077.) Neither maternal urinary or plasma fluoride 
was associated with offspring MDI scores (βurine = -0.631, p=0.391; βplasma= -0.0031, p=0.650.) 
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The effect of urinary or plasma fluoride on MDI also did not significantly change between the 
ages of 1, 2 and 3.  
Conclusions: This analysis suggests that maternal intake of fluoride during pregnancy does	  not	  have	  a	  strong	  impact	  on	  offspring	  cognitive	  development	  in	  the	  first	  three	  years	  of	  life. 
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II. Introduction
Artificial fluoridation has been used for nearly 60 years to reduce the prevalence of 
periodontal disease. An estimated 210 million people in the United States
1 and millions in thirty countries drink artificially or naturally fluoridated water.2 In the United 
States and other countries like Poland prenatal fluoride supplements have been administered as a 
measure to prevent childhood caries.3 ,4,5 Fluoride intake, however, has been connected to 
adverse outcomes like hypomineralization of dental enamel, skeletal fluorosis, and 
gastrointestinal pain.6,7,8
In children, adverse outcomes in relation to fluoride have centered on cognition, with a 
number of Chinese studies reporting an inverse association between fluoride exposure and 
intelligence quotient (IQ). These ecological studies found children living in high exposure 
communities had greater odds of having a lower IQ than their peers living in low exposure 
areas.9 One study measured urinary fluoride in an area with exposure similar to the United 
States, and found lower IQ correlated with higher urinary fluoride levels.10 These studies, 
however, do not use personal measures of exposure or adjust adequately for confounders.  
Adverse outcomes earlier in life - specifically during development - have not been 
studied well, but prenatal studies show that maternally ingested fluoride can traverse the 
placenta,11 the umbilical cord11,12 and the fetal blood-brain barrier to damage fetal brain tissue.
Once in the fetus, the levels of fluoride in the brain increase as maternal ingestion increases. 13,14 
Damage to brain tissue includes fewer or shrunken neurons,15 more unorganized Purkinje fibers 
in the cerebellum,13 and fewer neurotransmitters such as norepinephrine, 5-hydroxytryptamine, 
and α1-receptor.16 However, no studies have examined the association between prenatal fluoride 
exposure and its effects on human neurobehavior in early childhood.  
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This study reports on this association between maternal urinary and plasma fluoride from 
pregnancy and offspring neurobehavior at ages 1,2, and 3 for the first time. We use a multi-year 
birth cohort, the Early Life Exposure to Environmental Toxicants (ELEMENT) study, that 
measured prenatal fluoride exposure and then assessed neurobehavior when the subjects were 
aged one, two and three years old. Unlike existing studies that use ecological measures with a 
cross-sectional study design, we use the more reliable individual level of exposure, maternal 
urine and plasma, to assess prenatal fluoride exposure. We also examine if the association 
between fluoride and neurobehvior differs across child’s age.  
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III. Methods
Study Population: Study participants were recruited between 1997 and 2005 from three clinics of 
the Mexican Institute of Social Security (IMSS) in Mexico City, Mexico. Women with a positive 
pregnancy test, lived in Mexico City, willing to participate in a 3-year follow-up and planning to 
live in the area for five years were recruited. The women in the following categories were 
excluded from the study: those with psychiatric disorders, those who consumed alcohol daily or 
were addicted to illegal drugs, those who continuously used prescription drugs and those who 
were at risk for high-risk pregnancies, pre-eclampsia, renal or circulatory diseases including 
hypertension, those with gestational diabetes, those who suffered from seizures that required 
medical attention and those who were more than 14 weeks pregnant.17 The women who were 
eligible to participate were informed of the study procedures and they were recruited into the 
study after we obtained their written consent. Each women provided urine and plasma samples 
during the course of the pregnancy, and the children, once they were born, were administered the 
Bayley Scales of Infant Development test-II  (BSID-II.)  
We measured urinary fluoride in 695 women, and of these women, 431 women had a 
child with at least one MDI score: 355 children had an MDI score at age 1, 397 at age 2, and 358 
at age 3. Plasma fluoride was measured in 352 women, and 194 of these women had a child with 
atleast one MDI score: 194 children had an MDI score at age 1, 184 children at age 2 and 167 
children at age 3.  
Ethics: The Institutional Review Boards of the National Institute of Public Health of Mexico, 
University of Michigan and Harvard School of Public Health and participating clinics approved 
the study procedures. 
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Collection of Urine and Plasma: Spot urine and venous whole blood was collected once during 
each trimester of pregnancy. The samples were collected into fluoride-free containers, and the 
blood was collected into tubes with heparin and centrifuged to extract plasma. After field 
collection, the urine and plasma samples were immediately frozen at the field site and then 
shipped and stored at -200C at the Harvard School of Public Health (HSPH), and then at -800C at 
the University of Michigan School of Public Health (UMSPH). 
Urinary Fluoride: The fluoride content of the urine samples was measured using ion-selective 
electrode-based assays. First, 3 M sulfuric acid saturated with Hexamethyldisiloxane (HMDS) 
was added to the sample to allow fluoride to diffuse from the urine for 20-24 hours. The diffused 
fluoride was allowed to collect in 0.05 M of sodium hydroxide on the interior of the petri dish 
cover. Once the diffusion was complete, 0.25 M of acetic acid was added to the sodium 
hydroxide to neutralize the solution and an ion-selective electrode was used to measure the 
concentration of fluoride in this solution. The concentrations were calculated using a fluoride 
standard curve. None of the measured samples were below the average detection limit of 0.00656 
mg/L, the percent relative standard deviation for all samples was below 20% and the recovery 
rate was 100% for an urine standard reference material purchased from the National Public 
Health Institute of Quebec (INSPQ). The correlation coefficient between our measurements and 
those done at the Indiana University Oral Health Research Institute (IU-OHRI) was 0.80.  
Plasma Fluoride: Samples were selected for analysis in early 2013 and shipped frozen to the IU-
OHRI for fluoride analysis. Analysis of duplicate plasma samples was conducted using a 
modification of the hexamethyldisiloxane (HMDS) microdiffusion method of Taves18 as 
modified by Martinez-Mier et al.19 400 µl of diH2O were pipetted into plastic Petri dishes 
(Fisherbrand 35x10-mm disposable Petri dishes), followed by 200 µl of plasma sample or 
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standard.  After applying petroleum jelly to the inside of each Petri dish lid, 10 µl of 0.075 N 
sodium hydroxide (NaOH, A.R.) trap solution was placed in five equal drops on each dish 
lid.  Each dish was immediately sealed.  A small hole was burned into each lid into which will be 
pipetted 200 µl of HMDS-saturated 3 N SO4.  The hole was sealed immediately with petroleum 
jelly. During overnight diffusion, fluoride was released and trapped in the NaOH. The trap was 
recovered and buffered to pH 5.2 with 5 µl acetic acid (CH3COOH). The recovered solution was 
adjusted to a final volume of 20 ml with diH2O. A standard fluoride curve was prepared from 
similarly diffused fluoride standard solutions and used to determine fluoride content of each 
plasma sample. Millivolt readings were measured using a fluoride micro-electrode 
(Microelectrodes, Inc. MI-SO) and pH/ISE meter (Orion Dual Star or equivalent). Duplicate 
analyses were done in sets of approximately 30-40 samples.  0.01 ppm F, 0.2 ppm F and 5.0 ppm 
F standard checks were also be analyzed with each sample set. The percent relative percent 
standard deviation for all samples was below 20% and 100% of the standard reference material 
was recovered.   
Mental Development Index in Children: A Spanish-version of the Bayley Scales of Infant 
Development-II (BSID-II), the revised form of the Bayley Scales of Infant Development, was 
administered to the children at ages 1, 2 and 3 years by trained research staff to whom the 
prenatal fluoride status of the children was unknown. For quality control, random sessions were 
videotaped and reviewed by a psychologist.20 The Mental Development Index (MDI), scores 
were calculated after administering the test and the distributions were normalized for each age 
group. The mean of the MDI distribution is 100 and the standard deviation is 15.21  
Statistical Analysis: Summary statistics of urinary fluoride, plasma MDI and other continuous 
variables were generated to examine the distribution of these variables. Scatterplots and boxplots 
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were created to visualize the unadjusted relationship between MDI at ages 1, 2 and 3, and 
fluoride measures, as well as between MDI, fluoride measures and other continuous or 
categorical variables. The statistical significance of these bivariate associations was tested using 
t-tests, ANOVA or Spearmann correlations, as appropriate. Covariates included in the final 
model, were selected if they exhibited biological plausibility or if the fluoride association by 
10% or more. We ran two Generalized Additive Mixed Models (GAMM) using the average of 
available trimester-specific plasma or urine measures as the primary predictor. These models 
controlled for maternal age, education, marital status, pregnancy smoking status, child’s sex, and 
child’s age. Effect modification of the fluoride association by lead exposure was examined by 
adding an interaction between fluoride measures and lead concentration. Similarly, effect 
modification by child’s sex and age was also considered, and interactions between all covariates 
and child’s age and sex were examined to fit models equivalent to models stratified by age and 
sex. Only the effect of maternal age on child’s MDI varied by child’s age so, this interaction was 
retained in the final urine and plasma models. Continuous predictors were initially modeled 
using splines, and a non-linear relationship was seen between maternal education and child’s 
MDI in both models. The trimester-specific effect of fluoride on MDI was assessed by running 
GAMM models with trimester-specific fluoride measures as the primary predictors. All 
statistical analyses were completed on the statistical software R (Version 0.98.501) and the 
software Statistical Analysis System (Version 9.3) 
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IV. Results
Fluoride measurements were drawn from ELEMENT mothers (NUrine=431; Nplasma=194) 
for whom we had at least one prenatal biomarker.  Characteristics of the mothers in the sample 
were age: ~26.6 ± 5.5 years; maternal education: ~10.9 ± 3 years; 89.36% married or 
cohabitating; child’s sex: ~50% female, and did not differ statistically between the urine and the 
plasma groups.  
Each urine and plasma sample analyzed had detectable levels of fluoride. Urinary 
fluoride levels in this population of pregnant women ranged from 0.110 to 3.439 mg/L with a 
mean of 0.896.  Plasma fluoride levels were significantly lower than urinary fluoride levels with 
a mean of 0.0208 mg/L, and they ranged from 0.0035 to 0.0770 mg/L (Table 1). 
The final two models run to assess the effect of urinary fluoride and plasma fluoride on 
child’s MDI from ages one, two and three were Generalized Additive Mixed Models. Both 
models were adjusted for maternal age, maternal education, marital status, smoking status during 
pregnancy and child’s sex.  Urinary fluoride did not have a significant impact on MDI (β= -
0.631, p=0.391), and the same was true for plasma fluoride (β= -0.0031 p=0.650.) The 
association between maternal exposure and child’s MDI at each age was assessed using 
interaction terms, and none of the associations were significant.  
Trimester-specific models with urine or plasma as the main effect did not show any 
significant impact on the child’s MDI score. The effect of urine and plasma on MDI also did not 
vary by the child’s lead scores at ages one, two or three, and there were no significant 
interactions by child’s sex. When urine and plasma were placed in the same model, their 
associations with MDI did not change.  
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V. Discussion 
Overall, this investigation found no evidence of a detectable adverse outcome on 
offspring neurobehavioral development associated with maternal fluoride exposure during 
pregnancy. Fluoride measured in pregnancy urine and plasma was not significantly associated 
with child’s MDI at any age, and it did not differentially affect MDI at ages 1, 2, and 3. 
Furthermore, trimester-specific measures of maternal fluoride measures were not significantly 
associated with offspring MDI.  
We present these results with the use of personal measures of exposure, and with the use 
of rigorous statistical methods that have not been reported in previous studies. Most of the 
studies in this field report bivariate analyses of fluoride and IQ without adjusting for 
confounders, but our study ran reliable statistical models to account for the effect of these 
variables. Parental education, for example, is a known confounder of toxicant exposure and 
cognitive outcomes.22 In addition to parental education, we collected data on maternal marital 
status, maternal age, child’s age, and child’s sex and we adjusted for these variables in our 
models. The inverse trend we saw between fluoride and MDI in bivariate analysis disappeared 
once we adjusted for these confounders. 
There are currently only a few studies of cognitive measures that report personal 
measures of exposure, but this study uses two personal biomarkers to capture individual 
exposure to fluoride. Most of the existing studies on fluoride and neurobehavior used ecological 
measures of exposure and simply report the mean IQ across groups drinking water with different 
fluoride levels. 23,24,25 This method is prone to ecological fallacy, where the correlation between 
two variables at the group level is incorrectly assumed to equal the correlation at the individual 
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level. Our study, however, collected urine and plasma from each mother, allowing us to more 
directly assess exposure.  
The two biomarkers in this study also capture and assess the effects of acute and chronic 
exposure to fluoride. Urinary fluoride levels increase in the few hours after ingestion, and 
subsequently decrease as fluoride is excreted from the body.26 The handful of studies that report 
biomarkers only use urinary fluoride,10, 27 but plasma fluoride, due to an isoionic exchange of 
fluoride with bone, is a better measure of chronic exposure. Fluoride is deposited into the 
hydroxyapatite crystals of the bone over time,7 and when bone is remodeled some of the fluoride 
leaves and enters plasma, rendering it a proxy for the bone fluoride and chronic exposure.26 This 
measure and its potential effect on cognition is being reported for the first time in our study.   
Our results, however, should be treated with some degree of caution because we used 
spot urine and plasma samples. We do not report 24-hour urine measurements, and we do not 
report specific-gravity or creatinine-adjusted urine. Thus, the urine samples do not account for 
dilution, a measure that is difficult to adjust for in pregnant women. The spot plasma 
measurements do not capture the variation due to time of day, fasting vs. eating, and collection 
site of plasma. A study of nearly 500 individuals found serum fluoride levels dip in the morning 
and peak in the late evening, and it found the highest serum fluoride concentration 1-1.5 hours 
after ingestion.28 The plasma measurements used in this study do not capture this variation as the 
samples were collected at random points during the day, and participants were not required to 
fast before sample collection. There are also differences in venous and arterial plasma that are 
not captured by our plasma measurements. Immediately after ingestion, arterial plasma fluoride 
levels peak, but ten minutes after infusion is stopped, plasma levels are higher than arterial levels 
and remain that way for long time.26 Our study does not capture these variations.  
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The other limitation of this study was the sample size. Given the number of participants 
providing urine samples, we had to detect a 3-point difference in MDI scores per unit increase in 
urinary fluoride, to report an effect estimate with 80% power. This value is higher than the 
magnitude of 0.5 of MDI that we detected. This association between sample size and power was 
also true for the plasma analyses. Despite the low sample size, this is the only study to report 
personal measures of exposure to study the effect of fluoride on cognition in children.  
 Regardless of these limitations, this study provides critical answers regarding prenatal 
fluoride exposure in children. Maternal intake of fluoride during pregnancy does not have any 
measurable effects on cognition in early life. This maybe a case where the postnatal neuro-
system is more susceptible than the prenatal neuronal system, and  whether this means, that the 
nervous system recovers, or the effects may have disappeared over time, is not known. In 
addition to timing of exposure, a number of questions related to range of exposure, child’s age 
and type of neurobehavioral tests remain. We restricted our analysis to a lower range of exposure 
among children and we use one cognitive measure. The use of a higher sample size, the inclusion 
of concurrent exposure and wider ranges of exposure and ages, and more cognitive outcomes, 
therefore, remain considerations for future work in this area.  
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Tables	  and	  Figures	  
Table III.1: Descriptive characteristics of mother-infant pairs participating in the ELEMENT birth cohort 
study from Mexico City, Mexico. 
Urine Analysis (N=431) Plasma Analysis (N=194) 
Variable Mean ± SD Median Minimum, 
Maximum 
Mean ± SD Median Minimum, 
Maximum 
Maternal 
Characteristics 
Average Maternal 
Urinary Fluoride(mg/L) 
0.896 ± 0.478 0.831 0.110, 
3.439 
Average Maternal 
Plasma Fluoride (mg/L) 
0.02081 ± 
0.01573 
0.01600 0.00350, 
0.07700 
Maternal Age (years) 26.6 ± 5.5 26 14, 44 26.8 ± 6 26 14, 44 
Maternal Education 
(years) 
10.9 ± 2.8 11 2, 21 10.9 ± 2.9 11 3, 21 
Married/Cohabitating(
%) 
88.9 90 
Child Characteristics 
Child’s MDI at Age 
Two 
86.71 ± 11.59 86 52, 122 84.88 ± 
10.96 
86 52, 114 
Female Sex (%) 50.4 52.5 
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Table III. 2: Generalized Additive Mixed Models of maternal urinary and plasma fluoride 
during pregnancy and child’s MDI at ages one, two and three.  
Urine Analysis 
(N=431) 
Plasma Analysis 
(N=194) 
Variable β p-value β p-value 
Average urinary fluoride 
(mg/L) 
-0.631 0.391 
Average plasma fluoride 
(mg/L) 
-0.0031 0.651 
Maternal Age*Child’s Age 
1 year 0.0532 0.579 -0.113 0.347 
2 years 0.364 <0.01 0.181 0.108 
3 years 0.078 <0.01 0.039 0.664 
Child’s Sex (ref=male) 2.738 <0.01 3.001 <0.01 
Smoking during pregnancy 
(Ref=No) 
-1.645 0.600 2.081 0.570 
Marital Status 
(Ref=Married/cohabitating) 
1.440 0.257 -2.555 0.151 
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CHAPTER IV  
Concurrent Fluoride and Total WASI in 6-15 year old children from Mexico City, Mexico 
I. Abstract 
Background: Recent studies report an inverse association between fluoride exposure and IQ in 
children, but few of these studies report personal measures of exposure or adjust for confounders. 
Methods: This study utilizes the Cholesterol Cohort and its associated archived urine samples to 
study concurrent fluoride exposure and its association with subsequent child neurobehavioral 
outcomes in 6-15 year old children. Generalized Additive Mixed Models were used to model the 
association between urinary fluoride (N=550) and total score from the Wechsler Abbreviated 
Scale of Intelligence (WASI), adjusting for child’s sex, child’s age, maternal age, marital status, 
maternal education, family possessions, and cohort. GAM models were also run after stratifying 
by gender (NMales = 289, NFemales = 261.) 
Results: Urinary fluoride predicted higher WASI scores in children, but the association was only 
significant in males after stratifying by gender. (βmales = 3.98, p=0.05)  
Conclusion: This analysis suggests concurrent urinary fluoride exposure has a strong positive 
impact on cognitive development among males aged 6-15 years.  
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II. Introduction
Artificial fluoridation has been used for nearly 60 years to reduce the prevalence of 
periodontal disease. An estimated 210 million people in the United States
1  and millions in thirty countries drink artificially or naturally fluoridated water. 2 
Additionally, a number of publications recommend prenatal supplements as a measure to prevent 
childhood caries,3,4 and in some countries like Poland, women are given supplements during 
pregnancy.5 Fluoride intake, however, has also been connected to adverse outcomes. 6,7,8 
Among children and young people, the neurobehavioral studies, though weak in 
methodology, have received the most attention. They report an inverse association between 
fluoride exposure and IQ in school-age children. 9,10,11, 12, 13, 14, 15,16 The exposures in these 
studies, however, are ecological measures, where fluoride concentration of drinking water is 
assigned to individuals, or they are recall measures, where participants must remember the 
frequency of exposure. These methods are prone to a great amount of error and exposure 
misclassification, and they do not allow for accurate assessment of the neurobhevaioral effects of 
fluoride exposure. Most of these studies also fail to adequately adjust for confounders. Parental, 
familial and environmental factors such as maternal education, maternal age, family 
socioeconomic status and child’s age and education have well-known associations with cognitive 
function, but most studies report the neurobehavioral effects of fluoride without controlling for 
these factors. A review of the available literature, therefore, shows that the relationship between 
fluoride intake and cognitive function in children must be assessed using stronger, and more 
reliable methods.  
This study reports on the association between fluoride intake and child cognitive function 
using a cohort that measured concurrent urinary fluoride and neurobehavior in children aged 6-
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15 years old. Unlike existing studies that use ecological and recall measures, we use the more 
reliable individual level of exposure, urinary fluoride, to assess fluoride status. We also adjust for 
confounders that control for the effect of familial and environmental factors.  
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III. Methods
Study Population: Cholesterol and ELEMENT Cohorts 
The study participants for this project were 6-15 year old children who were recruited 
from the Early Life Exposure to ENvironmental Toxicants in Mexico City (ELEMENT) study 
for a follow-up study called Cholesterol. ELEMENT is a long-running, NIH-funded set of birth 
cohorts which recruited pregnant women with the original aim of studying the effects of prenatal 
lead exposure on developmental outcomes in early childhood. The first set of participants 
(Cohort 1) were approached and recruited between 1994 and 1997, the second set (Cohort 2) 
between 1997 and 2000, and the third set (Cohort 3) was approached and recruited between 2001 
and 2005. All of the women were recruited from the Mexican Institute of Social Security (IMSS) 
in Mexico City, Mexico during early pregnancy; those with a positive pregnancy test, who lived 
in Mexico City and who were willing to participate in the study were recruited. The women in 
the following categories were excluded from the study: those with psychiatric disorders, those 
who consumed alcohol daily or were addicted to illegal drugs, those who continuously used 
prescription drugs and those who were at risk for high-risk pregnancies, pre-eclampsia, renal or 
circulatory diseases including hypertension, those with gestational diabetes, those who suffered 
from seizures that required medical attention and those who were more than 14 weeks 
pregnant.17 Of the women-infant pairs recruited into the ELEMET cohorts, 827 pairs were 
eligible to participate in the Cholesterol study.  
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Ethics  
Mother’s consented to the study, children gave assent, and Institutional Review Board approval 
was granted at the University of Michigan and at National Institute of Public Health of Mexico. 
Urinary Fluoride 
For this analysis, 827 urine samples were collected in 5mL Fisherbrand containers when 
the children visited the National Institute of Public Health of Mexico (INSP) for their baseline 
visit. The samples were frozen at the field site before they were packaged on dry ice and shipped 
to the University of Michigan for storage in a -800C freezer. In mid-2013, 654 children’s urine 
samples remained in the freezers. These were thawed and measured for the free ionic form of 
fluoride using a gold-standard ion-selective electrode-based assay.18 Briefly, in this procedure, 
urine was diluted with equal parts Milli-Q water and 1 mL of the diluted urine was placed into a 
petri dish. It was mixed with 3 M sulfuric acid saturated with hexamethyldisiloxane (HMDS), 
and allowed to react for 20-24 hours. The diffused fluoride was collected in 0.05 M of sodium 
hydroxide that was spotted on the interior of the petri dish cover. Following neutralization with 
0.25 M of acetic acid, the concentration of fluoride in this solution was determined using an ion-
selective electrode.  
Several analytical quality control measures were used.  All laboratory glassware and 
plastic was acid-washed (cleaned, soaked overnight in 6M nitric acid followed by another 
overnight soak with 2M nitric acid) prior to use. Accuracy and precision were measured by use 
of urinary reference standards obtained from the Institut National de Santé Publique du Québec 
(INSPQ). The average recovery rate for the standards was 100%.  In addition, each batch 
contained procedural blanks and duplicate runs. The mean percent relative percent standard 
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deviation for all samples was below 20%. The analytical detection limit, calculated as the sum of 
the average and two times the standard deviation of duplicate blank values, was calculated for 
each batch. Samples that fell below the limit were excluded. The average analytical detection 
limit was 0.075 mg/L and the range was 0.034 mg/L-0.381mg/L. A subset of samples from the 
ELEMENT birth-cohort studies was also measured at the Indiana University Oral Health 
Research Institute (OHRI). The correlation coefficient between our measurements and those 
done at the Indiana University Oral Health Research Institute (OHRI) was 0.87.  
Wechsler Abbreviated Scale of Intelligence (WASI) 
A Spanish-version of the Wechsler Abbreviate Scale of Intelligence (WASI) was 
administered to the children during their baseline visit. Trained members of the Mexico team, to 
whom the fluoride status of the children was unknown, administered the test. Total WASI score, 
the measure assessed in this study, was calculated by combining sub-scores that measured verbal 
and executive function.  
Demographic and Socioeconomic Information 
 Demographic and socioeconomic information was collected during the baseline visit 
when the mothers were administered a questionnaire. The following variables were pulled from 
the questionnaire: child’s age, child’s sex, mother’s age, mother’s WAIS scores, mother’s current 
marital status and education of the head of the household. Data on family income level, however, 
is unavailable because it is culturally unacceptable to directly ask about earnings. The 
questionnaire instead approximated family income by asking about possessions such automobiles 
and electronics. The ownership of a computer, microwave, or car was awarded one point each, 
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and a new variable called “family possessions,” which is the sum total of these points was then 
generated. Those with the lowest score, owned the fewest items, and those with highest scores, 
conversely, owned the most items. The variable was not weighted. The covariates listed above 
were available for 550 mother-children pairs, of which 289 were male children, and 261 were 
female children.  
Statistical Analysis 
Summary variables such as mean, median, and range, and histograms of urinary fluoride, 
total WASI score and other continuous variables were generated to examine the distribution of 
these variables. A scatterplot was created to visualize the unadjusted relationship between the 
total WASI score and urinary fluoride, and the relationship, at the outset, appeared linear. 
Scatterplots and boxplots were also created to see if the relationship between the exposure 
variable and potential continuous covariates such child’s age, child’s sex, child’s BMI, maternal 
age, maternal marital status, maternal smoking status 1-month post-partum, mother’s WAIS 
Score, and ELEMENT cohort were linear. The same was done for the outcome variable and the 
potential covariates. Mean urinary fluoride and total WASI score was also tested across child’s 
sex, maternal marital status and maternal smoking status using the Student’s t-test, and the 
difference in means was tested across ELEMENT cohorts using the ANOVA test. The 
Spearmann correlation coefficient test was run to test the correlation between all variables. The 
covariates included in the final model were selected either on the basis of biological plausibility 
or if they changed the main effect by 10%. The final Generalized Additive Model (GAM) was as 
follows:   
Total WASIAll = βUrinary Fluoride + βChild’s Sex + βMaternal Age + βMarital Status + s (βMaternal Education) 
+ s (βFamily Possessions) + βCohort + βMother’s WAIS Score 
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GAM models were also run after stratifying by the child’s gender. In the final models, 
splines were added to maternal age, family possessions, and mother’s WAIS score among males, 
and on maternal education and family possessions among females. The final models were as 
follows: 
Total WASIMales = βUrinary Fluoride + βChild’s Sex + s(βMaternal Age) +  
βMarital Status + βMaternal Education + s (βFamily Possessions) + βCohort + s(βMother’s WAIS Score)
Total WASIFemales = βUrinary Fluoride + βChild’s Sex + βMaternal Age + βMarital Status + 
s (βMaternal Education) + s (βFamily Possessions) + βMaternal WAIS score + βCohort 
All statistical analyses were completed on the statistical software R (Version 0.98.501) and on 
the software Statistical Analysis Systems (Version: 9.3.) 
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IV. Results
Fluoride measurements were drawn from 6-15 year old children (N= 550) during their 
baseline visit in the Cholesterol study.  Characteristics of these children and their mothers 
(Child’s WASI Score: 94.6±11.5; child’s Age: 10.3 ±2.5 years; 47.5% female children; maternal 
age: 36.3 ± 5.8 years; maternal education: 10.7 ± 2.8 years; family possession: 7.6 ± 3.0 score 
and 79.6% married or cohabitating) were not statistically different from mother-children pairs for 
whom we did not have urinary fluoride.  
Of the urine samples we measured, all of them contained detectable levels of fluoride, 
and the mean concentration in this population was 0.640± 0.34 mg/L with a median of 0.597 
mg/L and a range of 0.123-2.812mg/L.  
To assess the adjusted effect of child’s fluoride levels on cognitive function, we ran 
GAM models, first in the overall population and then stratified by gender. In the overall 
population, urinary fluoride appears to have no significant impact on total WASI scores (β 
=1.32, p=0.33), but this association changes once the models are separated by male and female 
children. Male children showed a significantly positive trend (β=3.81, p=0.05), and females 
showing a negative trend that was not significant (β= -1.57, p=0.39). 
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V. Discussion 
Overall, this investigation found a significant positive impact on neurobehavioral 
development due to ingestion of fluoride in male children but no association was detected in 
female children. Fluoride measured in urine was significantly associated with total WASI score 
in male children ages 6 to 15 years old. We present these results with the use personal measures 
of exposure, and with the use of rigorous statistical methods that have not been reported in 
previous studies.  
Most of the studies in this field report bivariate analyses of fluoride and IQ without 
adjusting for confounders, but our study ran reliable statistical models to account for the effect of 
these variables. Parental education, for example, is a known confounder of toxicant exposure and 
cognitive outcomes.19 In addition to parental education, we collected data on maternal marital 
status, maternal age, child’s age, and child’s sex and we adjusted for these variables in our 
models.  
Most of the studies on fluoride exposure and IQ use either ecological measures of 
exposure or recall measures, leaving these studies prone to a lot of error. Most of the existing 
studies on fluoride and neurobehavior used ecological measures of exposure and simply report 
the mean IQ across groups drinking water with different fluoride levels. 20,21,22 This method is 
prone to ecological fallacy, an incorrect interpretation of the statistical data where correlation 
between two variables at the group level is assumed to equally correlate at the individual level. 
Our study, however, has directly measured fluoride in each individual by collection urine 
samples from all participants.  
Despite a number of strengths (e.g., large sample size, adjusting for confounders and 
personal measures of exposure), there are potential limitations of our study that need mention.  
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The spot urine samples we measured cannot account for diurnal variations in urinary fluoride. 
Previous studies report fluctuations in concentration by time-of-day23 which means that the 
fluoride levels in our samples could be influenced by the time-of-collection or by diet. 
Additionally, we lack information on family socioeconomic status (SES), and there may be 
residual confounding from this factor that cannot be adjusted for in this study. SES, for example, 
is known to be associated with food intake, which in turn can affect fluoride levels. SES is also 
highly correlated with our outcome variable, cognition. To address these limitations, future 
studies should either provide 24-hour measures or measure samples that have been collected at a 
standard time, and they should provide information on SES.  
Additionally, we do not have plasma fluoride measures, which may account for the 
differences in association found between males and female children. In this study, urinary 
fluoride had a significant positive impact on male children but not on female children, but this 
association could change once plasma fluoride is added in the model. First, plasma fluoride is 
correlated to urinary fluoride, and second, plasma fluoride could provide a measurement of the 
fluoride released from bone during the drastic changes in bone growth and metabolism during 
puberty. Male children have higher rates of bone resorption during puberty than their female 
counterparts24, which could release more fluoride stored in bone and increase circulating levels 
of plasma fluoride, which could affect cognition. So, future studies should account for this 
critical confounder.  
Despite these limitations, this work provides the most reliable assessment of urinary 
fluoride and cognition in children, and we found that WASI scores increase in male children as 
fluoride intake increases. These results were surprising in that they show opposite trends to what 
has been reported in the literature so, more studies with similar reliable methodology, which 
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account for plasma fluoride, diurnal variations in urinary fluoride and children’s SES, are 
needed. If these results are substantiated, different fluoride interventions may be needed for male 
children versus female children. 
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Table IV.1: Descriptive Statistics of Mother-child pairs recruited into the Cholesterol cohort in Mexico City, Mexico. 
ALL MALES FEMALES 
Variable N Mean ± 
SD 
Median Range N Mean 
± SD 
Median Range N Mean 
± SD 
Median Range 
Child variables 
Urinary 
Fluoride 
550 0.640± 
0.34 
0.597 0.123, 
2.812 
289   0.67 
±0.34 
0.62 0.123, 
2.81 
261 0.61±
0.33 
0.55 0.14, 
2.41 
Total WASI 
Score 
550 94.6± 
11.5 
94.5 66, 133 289 95.1 
±12.0 
95 66,128 261 94.1 
±10.9 
94 66, 
133 
Age 550 10.3± 
2.5 
9.9 6.6, 
15.7 
289 10.5±
2.5 
9.9 6.9, 
15.5 
261 10.1±
2.5 
9.7 6.6, 
15.7 
Female Sex (%) 47.5 --- --- 
Maternal 
Variables 
WAIS Total 
Score 
550 87.5± 
12.7 
87 51, 
130 
289 86.8± 
12.8 
86 51, 130 261 88.3 
±12.5 
88 53, 
117 
Age 550 36.3± 
5.8 
36 24, 
56 
289 36.3±
5.8 
36 24, 56 261 36.4 
±5.7 
36 24, 
53 
Family 
Possessions 
550 7.6± 
3.0 
7 1, 16 289 7.8 
±3.1 
8 1, 16 261 7.4± 
2.9 
7 1, 16 
Maternal 
Education 
550 10.7 
±2.8 
11 1,18 289 10.6 
±2.7 
11 1, 17 261 10.6 
±2.8 
11 2,18 
Married/ 
Cohabitating(%) 
79.6 82.4 76.6 
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*Asterisk denotes splines
Table IV.2: Generalized Additive Models of Urinary fluoride and WASI among children in the 
Cholesterol Cohort from Mexico City, Mexico. 
ALL$ MALES (N=289) FEMALES* 
(N=261) 
Variable β p-value β p-value β p-value 
Urinary fluoride 1.32 0.33 3.81 0.05 -1.57 0.39 
Child’s Sex (ref=female) 1.53 0.09 
Maternal Age  0.05 0.57 * * -0.10 0.38 
Marital Status 
(Ref=married/cohabitating) 
0.44 0.71 -1.69 0.36 1.56 0.29 
Maternal Education * 0.07 0.58 0.05 * 0.18
Family Possessions * 0.40 * 0.70 * 0.17
Cohort 2 BL (Ref=Cohort 1) 2.61 0.05 2.53 0.19 3.44 0.05 
Cohort 2 PL (Ref= Cohort 1) 3.20 0.02 1.28 0.53 6.28 <0.01 
SF Cohort (Ref=Cohort 1) 3.61 <0.01 3.82 0.07 4.33 0.02 
Mother’s WAIS Score 0.30 <0.01 * * 0.34 <0.01 
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Figure IV.1: Child’s urinary fluoride and total WASI score adjusted for child’s Sex, child’s age, 
maternal age, marital status, maternal education, family possessions, and cohort in the entire 
population. 
Figure IV.2: Child’s urinary fluoride and total WASI score adjusted for Child’s Sex, child’s age, 
maternal age, marital status, maternal education, family possessions, mother’s WAIS score and 
cohort among female children.  
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CHAPTER V 
Conclusion 
I. Overview 
This work increases our understanding of prenatal and concurrent fluoride intake and its 
effects on cognition in children. In chapter II, we describe, for the first time, urinary and plasma 
fluoride levels in pregnant women. We also examined exposure trends from the first month 
through delivery and found that the concentration of fluoride, once adjusted for other factors, 
does not change as pregnancy progresses. We also show that older women and those who carry 
male children maybe more susceptible to fluoride exposure. In chapter III, fluoride measured in 
pregnancy urine and plasma was not significantly associated with child’s Mental Development 
Index (MDI) in early childhood and it did not differentially affect MDI over a three-year period. 
In Chapter IV, we find no detectable adverse outcomes on offspring neurobehavioral 
development due to simultaneous intake of fluoride, but a significant positive impact on 
Wechsler Abbreviated Scales of Intelligence (WASI) scores was seen in male children. We 
present the results in these three chapters with the use personal measures of exposure, and with 
the use of rigorous statistical methods that have not been reported in previous studies.  
II. Chapter II
This is the first study to report urinary and plasma fluoride levels in hundreds of pregnant 
women from a population drinking fluoridated water at levels recommended by the U.S. Public 
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Health Service. Urinary fluoride ranged from 0.902-3.439 mg/L and plasma fluoride range from 
0.004-0.077 mg/L. The levels of fluoride in maternal urine and plasma reported within this study 
are similar in range to other reports. In a study where women drank 1 mg/L of fluoridated water, 
urinary fluoride ranged from 0.22 to 0.53 mg/L.1 In a controlled clinical study, pregnant women 
taking fluoride supplements had a mean urinary fluoride of 1.03±0.14mg/day in early 
pregnancy.2  The wider range of urinary fluoride found in this study could be explained by 
higher levels of exposure in our population. Similarly, the plasma levels we report in this study 
are comparable to the levels reported in other studies on pregnant women. The most recent study, 
from Poland, measured 0.0329-0.0373 mg/L of plasma fluoride in 35 women during the third 
trimester of pregnancy,3 while other studies measured a range of 0.011-0.050 mg/L of plasma 
fluoride in five women,4 a mean of 0.033±0.003 mg/L in 50 women5 and 0.97±0.22 (first 
trimester), 0.90±0.25 (second trimester), 0.86±0.18micromol/liters in 68 women.6  
An issue of increasing importance is determining whether there are time-related exposure 
windows of susceptibility to toxicant exposures especially during the prenatal period. Many lines 
of evidence now indicate such, including previous work by us concerning lead exposure in the 
ELEMENT cohort.7,8 Here we were able to study whether fluoride levels vary in urine and 
plasma as pregnancy progressed, however we only saw changes on the individual level while the 
population averages remained stable throughout pregnancy. This was somewhat surprising to us 
as a number of physiological and metabolic changes occur during pregnancy that could affect 
fluoride toxicokinetics. Previous studies reported significantly different levels of exposure 
between different periods of gestation. One study from Jerusalem, for example, reports an U-
shaped distribution with the highest concentration of urinary fluoride measured in the fourth and 
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ninth months of pregnancy.9 The other study on plasma pregnancy did not report any significant 
differences in plasma fluoride between the 28th and the 33rd week of pregnancy.3  
Here we were also able to study urinary and plasma fluoride values in relation to key 
demographic variables.  The strongest changes in plasma fluoride were in relation to maternal 
age, with older mothers reporting significantly higher levels of plasma fluoride.  This may be 
explained by the exchange of fluoride between plasma and bone during the aging process. 
Ingested fluoride is absorbed through the gut, taken into the plasma, and then deposited into the 
bone. As the organism ages, the hydroxyapatite mineral in bone becomes saturated with fluoride, 
and further deposition of the ion from plasma is prevented.10,11 In animal studies, older dogs12 
and rats13 had more fluoride in their plasma than their younger counterparts, further supporting 
the theory that fluoride remains in the plasma or is excreted through the urine than deposited in 
the bone. There are, however, no such studies on plasma clearance in pregnant animals or 
humans so, this warrants more study.  
Finally, we have limited evidence that suggests that urinary fluoride may be higher in 
women who smoke during pregnancy. This increase may be explained by the mobilization of 
fluoride during bone resorption. Fetal demands for calcium, particularly during the third 
trimester, increase the rate of bone breakdown to release the mineral into the bloodstream.14,15,16 
To our knowledge, the effect of smoking on this process during pregnancy has not been studied; 
however, the catalytic effect of smoking on bone resorption in non-pregnant adults has been well 
documented.17 Higher concentrations of the deoxypyridinoline, C-telopeptide,18 and N-
telopeptide, 19 markers of bone breakdown, were measured in smokers. When bone resorption 
exceeds bone formation, as is the case in smokers, the amount of fluoride released from the bone 
increases without an increase of incorporation of fluoride into the bone.10 We hypothesize that 
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urinary fluoride levels, in turn, increase as the body attempts to clear the release of excess 
fluoride from the bones.  
This work provides the most reliable characterization to date of urinary and plasma 
fluoride throughout the duration of pregnancy. Our values were similar to the ones reported in 
previous studies, but contrary to other reports, our analysis did not show a significant trend in 
urine or plasma fluoride once we adjusted for maternal and demographic factors. The two 
biomarkers were largely stable from the first to the last month of pregnancy. Interestingly, 
mothers who smoke seem to have the highest amount of urinary fluoride, and older mothers have 
the highest plasma fluoride, indicating that fetal exposure could be higher among smokers and 
older women. These results will be used in future studies related to health outcomes research 
such as prenatal fluoride exposure and neurobehavior. 
III. Chapter III
Overall, this investigation found no evidence of a detectable adverse outcome on 
offspring neurobehavioral development associated with maternal fluoride exposure during 
pregnancy. Fluoride measured in pregnancy urine and plasma was not significantly associated 
with child’s MDI at any age, and it did not differentially affect MDI at ages 1, 2, and 3. 
Furthermore, trimester-specific measures of maternal fluoride measures were not significantly 
associated with offspring MDI.  
We present these results with the use of personal measures of exposure, and with the use 
of rigorous statistical methods that have not been reported in previous studies. Most of the 
studies in this field report bivariate analyses of fluoride and IQ without adjusting for 
confounders, but our study ran reliable statistical models to account for the effect of these 
variables. Parental education, for example, is a known confounder of toxicant exposure and 
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cognitive outcomes.20 In addition to parental education, we collected data on maternal marital 
status, maternal age, child’s age, and child’s sex and we adjusted for these variables in our 
models. The inverse trend we saw between fluoride and MDI in bivariate analysis disappeared 
once we adjusted for these confounders. 
There are currently only a few studies of cognitive measures that report personal 
measures of exposure, but this study uses two personal biomarkers to capture individual 
exposure to fluoride. Most of the existing studies on fluoride and neurobehavior used ecological 
measures of exposure and simply report the mean IQ across groups drinking water with different 
fluoride levels. 21,22,23 This method is prone to ecological fallacy, where the correlation between 
two variables at the group level is incorrectly assumed to equal the correlation at the individual 
level. Our study, however, collected urine and plasma from each mother, allowing us to more 
directly assess exposure.  
The two biomarkers in this study also capture and assess the effects of acute and chronic 
exposure to fluoride. Urinary fluoride levels increase in the few hours after ingestion, and 
subsequently decrease as fluoride is excreted from the body.24 The handful of studies that report 
biomarkers only use urinary fluoride, 25 but plasma fluoride, due to an isoionic exchange of 
fluoride with bone, is a better measure of chronic exposure. Fluoride is deposited into the 
hydroxyapatite crystals of the bone over time, and when bone is remodeled some of the fluoride 
leaves and enters plasma, rendering it a proxy for the bone fluoride and chronic exposure.26 This 
measure and its potential effect on cognition is being reported for the first time in our study. 
In conclusion, the prenatal study found that maternal intake of fluoride during pregnancy 
does not have any measurable effects on cognition in early life. This maybe a case where the 
postnatal neuro-system is more susceptible than the prenatal neuronal system, and whether this 
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means, that the nervous system recovers, or the effects may have disappeared over time, is not 
known. In addition to timing of exposure, a number of questions related to range of exposure, 
child’s age and type of neurobehavioral tests remain. We restricted our analysis to a lower range 
of exposure among children and we use one cognitive measure. The use of a higher sample size, 
the inclusion of concurrent exposure and wider ranges of exposure and ages, and more cognitive 
outcomes, therefore, remain considerations for future work in this area. 
VI. Chapter IV
Overall, this investigation found a significant positive impact on neurobehavioral 
development due to ingestion of fluoride in male children but no association was detected in 
female children. Fluoride measured in urine was significantly associated with total WASI score 
in male children ages 6 to 15 years old. We present these results with the use personal measures 
of exposure, and with the use of rigorous statistical methods that have not been reported in 
previous studies.  
Most of the studies in this field report bivariate analyses of fluoride and IQ without 
adjusting for confounders, but our study ran reliable statistical models to account for the effect of 
these variables. Parental education, for example, is a known confounder of toxicant exposure and 
cognitive outcomes.26 In addition to parental education, we collected data on maternal marital 
status, maternal age, child’s age, and child’s sex and we adjusted for these variables in our 
models.  
Most of the studies on fluoride exposure and IQ use either ecological measures of 
exposure or recall measures, leaving these studies prone to a lot of error. Most of the existing 
studies on fluoride and neurobehavior used ecological measures of exposure and simply report 
the mean IQ across groups drinking water with different fluoride levels. 27,28,29 This method is 
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prone to ecological fallacy, an incorrect interpretation of the statistical data where correlation 
between two variables at the group level is assumed to equally correlate at the individual level. 
Our study, however, has directly measured fluoride in each individual by collection urine 
samples from all participants.  
This work provides the most reliable assessment of urinary fluoride and cognition in 
children, and we found that WASI scores increase in male children as fluoride intake increases. 
These results were surprising in that they show opposite trends to what has been reported in the 
literature so, more studies with similar reliable methodology, which account for plasma fluoride, 
diurnal variations in urinary fluoride and children’s SES, are needed. If these results are 
substantiated, different fluoride interventions may be needed for male children versus female 
children. 
V. Limitations and future considerations 
Despite a number of strengths (e.g., large sample size, adjusting for confounders and 
personal measures of exposure), there are potential limitations of our study that need mention.  
The spot urine samples we measured cannot account for diurnal variations in urinary fluoride. 
Previous studies report fluctuations in concentration by time-of-day30 which means that the 
fluoride levels in our samples could be influenced by the time-of-collection or by diet. Future 
studies should either provide 24-hour measures or measure samples that have been collected at a 
standard time. This study was also not initially designed to address fluoride exposure, but we 
have a strong biomarker and the fluoride levels we measured was similar to previous reports.  
In addition to spot urine samples, in the prenatal study, we restricted our analysis to a lower 
range of prenatal exposure and we only use one cognitive measure. So, the use of concurrent 
exposure, with wide range of exposure and more cognitive outcomes in older children, remain 
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considerations for future work in this area. Also, the concurrent fluoride study is cross-sectional, 
having only collected exposure and outcome measures from one timepoint. So, questions related 
to temporality remain, and they can only be resolved once data is collected at multiple 
timepoints.  
In chapter 4, we lack information on family socioeconomic status (SES), and there may 
be residual confounding from this factor that cannot be adjusted for in this study. SES, for 
example, is known to be associated with food intake, which in turn can affect fluoride levels. 
SES is also highly correlated with our outcome variable, cognition. To address these limitations, 
future studies should either provide 24-hour measures or measure samples that have been 
collected at a standard time, and they should provide information on SES.  
Additionally, in chapter 4, we do not have plasma fluoride measures, which may account 
for the differences in association found between males and female children. In this study, urinary 
fluoride had a significant positive impact on male children but not on female children, but this 
association could change once plasma fluoride is added in the model. First, plasma fluoride is 
correlated to urinary fluoride, and second, plasma fluoride could provide a measurement of the 
fluoride released from bone during the drastic changes in bone growth and metabolism during 
puberty. Male children have higher rates of bone resorption during puberty than their female 
counterparts31, which could release more fluoride stored in bone and increase circulating levels 
of plasma fluoride, which could affect cognition. So, future studies should account for this 
critical confounder.  
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